At the intersection of nanotechnology and life sciences, nano-biotechnology & biomaterials is pioneering innovations that are reshaping diagnostics, therapeutics, and tissue engineering. Nanoscale systems such as quantum dots, liposomes, and dendrimers are being designed for targeted drug delivery and molecular imaging. Meanwhile, smart biomaterials are engineered to respond to biological stimuli, facilitating controlled release and promoting tissue regeneration. These materials, often biocompatible and biodegradable, are crucial in designing scaffolds, implants, and biosensors with enhanced performance. Nano-Biotechnology & Biomaterials also plays a transformative role in cancer treatment, regenerative therapies, and point-of-care diagnostics. With continuous advancements in surface modification and nanofabrication techniques, this field continues to merge precision with functionality across diverse biomedical and industrial platforms.
Title : Why do 90% of the drugs fail in development? An analysis of 82+ submissions; and a case study of immunotherapy
Narendra Chirmule, Indian Institute of Technology (IIT), India
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Ancient wisdom, modern science: Biotech services transforming ayurveda
Prashant Sakharam Bhokardankar, Datta Meghe Ayurvedic Medical College Hospital and Research Centre, India
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain